During one study, physicians at Walter Reed plan to give the psychedelic drug MDMA to up to 450 active-duty soldiers with ...

In March 2025, Beckley Psytech completed patient enrollment in the eight-week, double-blind, core stage of the global Phase ...

Natural products industry companies share overviews on the latest science on their branded ingredients and formulations to ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

Galcanezumab provided greater reductions in migraine frequency, resulting in a shift from chronic to episodic migraine over a 12-month period compared with placebo.

Magnesium and melatonin are commonly used as sleep aids, though their effects are generally modest. Learn how they work and ...

Topline data were announced from a phase 3 trial evaluating ecopipam in pediatric and adult patients with Tourette syndrome.

Weight loss supplements are a big industry, but do they actually work? A dietitian explores the evidence, efficacy, and ...

Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO ...

Biodexa Pharmaceuticals (BDRX) announced the appointment of Precision for Medicine as the clinical research organization, CRO, to conduct the ...

Record Year with Total 2024 Revenues of $161.0 Million, Representing a 13% Increase over Fiscal Year 2023 and Adjusted EBITDA of $34.1 Million, Up 42% Year-over-Year, and a 21% Margin of RevenuesCash ...

According to a randomized, double-blind, double-dummy human laboratory trial conducted by researchers from researchers from ...